Business Wire

  1. Invivoscribe Expands Flow Cytometry Services To Accelerate CAR-T Immunotherapy Development And Regulatory Readiness With The Initiation Of CERo Therapeutics Phase 1 Clinical Trial 7/8/2025

    Invivoscribe Inc., a global leader in precision diagnostics and measurable residual disease (MRD) testing, is proud to support CERo Therapeutics Holdings, Inc., an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms.

  2. Bio-Rad Expands Droplet Digital PCR Offering Through Strategic Acquisition And Platform Rollout 7/7/2025

    Bio-Rad Laboratories, Inc. a global leader in life science research and clinical diagnostics products, today announced the launch of four new Droplet Digital PCR (ddPCR) platforms.

  3. Thermo Fisher's NGS Assay Receives FDA Approval As A Companion Diagnostic For ZEGFROVY And For Tumor Profiling 7/3/2025

    Thermo Fisher Scientific, the world leader in serving science, today announced the U.S. Food and Drug Administration (FDA) has approved the Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer as an in vitro diagnostic (IVD) assay for use as a companion diagnostic (CDx) for Dizal’s ZEGFROVY (sunvozertinib) and in tumor profiling.

  4. STEMCELL Technologies Introduces STEMprep Tissue Dissociator System To Accelerate Research Discoveries 6/27/2025

    To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes.

  5. Galatea Bio And Fabric Genomics Partner To Deliver Comprehensive Genetic Testing For Common Diseases 6/23/2025

    Galatea Bio and Fabric Genomics, a GeneDx company, announced today a strategic collaboration to enhance genetic testing by incorporating both rare pathogenic variant analysis and polygenic risk scoring (PRS) to assess genetic susceptibility to common diseases.

  6. Quanterix Expands Reach With IVD And Large Reference Labs 6/23/2025

    Quanterix Corporation a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that the HD-X Simoa Immunoassay Analyzer has received Class 1 Medical Device registration by the Ministry of Food and Drug Safety (MFDS) in South Korea through its regional distribution partner, HS Biosystems.

  7. QIAGEN And GENCURIX Announce QIAcuity Digital PCR IVD Assay Development Partnership 6/18/2025

    QIAGEN and GENCURIX, Inc. today announced a new partnership to develop oncology assays for use on the QIAcuityDx platform, a high-performance digital PCR system designed for clinical diagnostics.

  8. Seek Labs Unveils BioSeeker 6/10/2025

    Seek Labs—a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics—today announced BioSeeker, a next-generation AI discovery engine redefining how the world identifies and treats disease.

  9. Bruker Announces Acquisition Of biocrates, A Leader In Mass Spectrometry-Based Quantitative Metabolomics 6/3/2025

    Bruker Corporation today announced the acquisition of biocrates life sciences ag, located in Innsbruck, Austria. Financial terms were not disclosed.

  10. hc1 Introduces Outreach Optimization Solution To Drive Laboratory Success 6/3/2025

    hc1 introduced today its new Outreach Optimization solution, designed to transform how clinical laboratories expand their outreach programs, strengthen provider relationships, and drive new revenue.